Empaglimet 12.5/500mg Tablet — Empagliflozin + Metformin
Pay in 3 Installments of
Rs.
168
JazzCash
easypaisa
NayaPay
Bank transfer
Cash on Delivery
Description
Empaglimet 12.5/500mg Tablet is a fixed-dose combination of Empagliflozin 12.5mg (SGLT2 inhibitor) and Metformin 500mg (biguanide), prescribed for adults with Type 2 Diabetes Mellitus requiring dual pharmacological therapy for glycaemic control.
Empagliflozin promotes urinary glucose excretion independent of insulin, providing proven cardiovascular and renal protective benefits. Metformin decreases hepatic glucose production and improves insulin sensitivity without causing hypoglycaemia as monotherapy.
For patients requiring triple therapy, consider Exempa Lin Met XR 12.5/2.5/1000mg Tablet (Empagliflozin + Linagliptin + Metformin XR). For sulfonylurea-based add-on therapy, see Zeenaryl 2mg Tablets (Glimepiride).
Safety Information: Not for Type 1 diabetes or diabetic ketoacidosis. Contraindicated in severe renal impairment (eGFR <30). Monitor kidney function regularly. Rx only — valid prescription required. Email prescription to sales@derma.pk or WhatsApp +92-320-5999650.
Usage & Benefits
- Dual-action blood sugar control via SGLT2 inhibition and biguanide mechanisms
- Promotes urinary glucose excretion independent of insulin
- Reduces hepatic glucose production and improves insulin sensitivity
- Proven cardiovascular and renal protective benefits
- Convenient fixed-dose combination reducing pill burden
How To Use
1. Take Empaglimet 12.5/500mg as prescribed by your doctor.
2. Administer with meals to reduce gastrointestinal side effects from Metformin.
3. Swallow the tablet whole with a glass of water.
4. Take at the same time each day for consistent glycaemic control.
5. Monitor blood glucose and kidney function regularly during treatment.
6. Use only as directed by your healthcare provider.
FAQs
What is Empaglimet 12.5/500mg used for?
It is a prescription combination tablet for adults with Type 2 Diabetes Mellitus, combining Empagliflozin and Metformin to improve blood sugar control and protect the heart and kidneys.
Does Empaglimet cause weight loss?
Yes, modest weight reduction may occur due to urinary glucose excretion caused by the Empagliflozin component.
Can patients with kidney disease use Empaglimet?
Use with caution. It is contraindicated in severe renal impairment (eGFR <30 mL/min/1.73m²). Your doctor will assess kidney function before prescribing.
